Issue link: https://www.e-digitaleditions.com/i/1218534
22 March 2020 Tablets & Capsules Recro Gainesville CDMO provides development, regulatory support, clinical and commercial manufacturing, packaging, and logistics services for oral solid dosage forms. Company specializes in modified-release formulations, complex reformula- tions, and DEA-controlled substances. Its 120,000-square-foot facility supports clients' pharmaceutical development and manufacturing projects from concept through commercialization. Recro Gainesville, Gainesville, GA 770 534 8239 www.recrogainesville.com Trividia Manufacturing Solutions Company provides contract manufacturing and packaging services for topical OTC drugs, dietary supplements, homeopathic products, cosmetics, and ani- mal feed supplements in liquid, lotion, cream, gel, and tablet forms. Offerings include R&D services, pilot stability, formulation, and process development. Secondary packaging for customized pack-out options include display cartons, bundling, and a variety of tray configurations. Each project is customized to meet client specifications. Trividia Manufacturing Solutions, Lancaster, NH 603 788 4952 www.trividiams.com Metrics Contract Services Full-service pharmaceutical CDMO specializes in pharmaceutical oral dosage forms. Services include formulation development, first-time-in-man formulations, Phase I-III clinical trial materials manufacturing, and analytical method develop- ment and validation services through commercial-scale manufacturing. Company's technical capabilities include highly potent, cytotoxic, and unstable compounds; Schedule II-V controlled substances; and improving products with poor bioequiv- alence. Recent infrastructure upgrades, including a 126,000-square-foot oral dose commercial manufacturing facility, allow the CDMO to offer clients complete concept-to-commercialization services at a single site. Metrics Contract Services, Greenville NC 252 752 3800 www.metricscontractservices.com PCI Pharma Services CDMO launches more than 50 products per year and provides drug develop- ment and manufacturing services throughout the product life cycle, from Phase 1 clinical trials through commercialization and ongoing supply. Services include formulation and analytical development, clinical trial supply, and commercial manufacturing of solid oral dose, powders, liquids, and semisolids. These services are supported by in-house packaging and labeling services as well as on-site testing and release services. CDMO's Tredegar, UK, site supplies global markets, includ- ing the US, South America, Europe, and Japan. PCI Pharma Services, Philadelphia, PA 779 774 1428 www.pciservices.com